Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Histiocytosis, Langerhans-Cell | 13 | 2024 | 284 | 3.640 |
Why?
|
| Xanthogranuloma, Juvenile | 2 | 2022 | 39 | 0.960 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 6 | 2024 | 183 | 0.910 |
Why?
|
| Histiocytosis, Sinus | 1 | 2022 | 87 | 0.780 |
Why?
|
| Histiocytosis | 1 | 2020 | 56 | 0.690 |
Why?
|
| Telomere Shortening | 1 | 2019 | 56 | 0.640 |
Why?
|
| Benzimidazoles | 1 | 2022 | 442 | 0.640 |
Why?
|
| Pneumothorax | 1 | 2020 | 166 | 0.630 |
Why?
|
| Proto-Oncogene Proteins B-raf | 4 | 2024 | 1331 | 0.550 |
Why?
|
| Leukemia, Biphenotypic, Acute | 1 | 2016 | 50 | 0.530 |
Why?
|
| Telomerase | 1 | 2019 | 543 | 0.520 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2019 | 408 | 0.500 |
Why?
|
| Neutropenia | 1 | 2019 | 1001 | 0.480 |
Why?
|
| Lung Diseases | 1 | 2020 | 755 | 0.470 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 522 | 0.470 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2016 | 320 | 0.450 |
Why?
|
| Rituximab | 1 | 2018 | 1588 | 0.440 |
Why?
|
| Hodgkin Disease | 2 | 2019 | 1488 | 0.430 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2022 | 682 | 0.370 |
Why?
|
| Glioma | 1 | 2022 | 1988 | 0.370 |
Why?
|
| Histiocytes | 2 | 2022 | 95 | 0.350 |
Why?
|
| Mutation | 4 | 2019 | 15944 | 0.350 |
Why?
|
| Fever of Unknown Origin | 2 | 2018 | 61 | 0.310 |
Why?
|
| Infant | 12 | 2024 | 13970 | 0.310 |
Why?
|
| Child, Preschool | 12 | 2024 | 17056 | 0.290 |
Why?
|
| Child | 16 | 2024 | 30559 | 0.280 |
Why?
|
| Adolescent | 15 | 2024 | 32730 | 0.270 |
Why?
|
| Skin Neoplasms | 1 | 2023 | 4890 | 0.260 |
Why?
|
| Genes, Neurofibromatosis 2 | 1 | 2004 | 17 | 0.240 |
Why?
|
| Kidney Transplantation | 2 | 2018 | 792 | 0.210 |
Why?
|
| MAP Kinase Signaling System | 2 | 2024 | 889 | 0.200 |
Why?
|
| Interferon-gamma | 2 | 2022 | 1180 | 0.190 |
Why?
|
| Humans | 30 | 2024 | 272087 | 0.190 |
Why?
|
| Meningioma | 1 | 2004 | 307 | 0.190 |
Why?
|
| Pleurodesis | 1 | 2020 | 70 | 0.180 |
Why?
|
| Thiotepa | 1 | 2020 | 132 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2022 | 384 | 0.170 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2020 | 718 | 0.170 |
Why?
|
| Meningeal Neoplasms | 1 | 2004 | 473 | 0.170 |
Why?
|
| Chest Tubes | 1 | 2020 | 118 | 0.170 |
Why?
|
| Signal Transduction | 2 | 2017 | 12223 | 0.160 |
Why?
|
| Etanercept | 1 | 2018 | 69 | 0.160 |
Why?
|
| Blood Cells | 1 | 2019 | 130 | 0.160 |
Why?
|
| Remission Induction | 2 | 2023 | 3645 | 0.160 |
Why?
|
| Sepsis | 2 | 2021 | 689 | 0.160 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2021 | 382 | 0.160 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2024 | 4963 | 0.150 |
Why?
|
| Smad6 Protein | 1 | 2017 | 14 | 0.150 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2024 | 16612 | 0.150 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 2357 | 0.150 |
Why?
|
| Osteopontin | 1 | 2018 | 148 | 0.150 |
Why?
|
| STAT1 Transcription Factor | 1 | 2018 | 162 | 0.150 |
Why?
|
| Graft Rejection | 2 | 2018 | 865 | 0.150 |
Why?
|
| Young Adult | 6 | 2024 | 22142 | 0.140 |
Why?
|
| Janus Kinases | 1 | 2018 | 175 | 0.140 |
Why?
|
| Cytarabine | 1 | 2023 | 2014 | 0.140 |
Why?
|
| Male | 17 | 2024 | 129088 | 0.140 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2020 | 609 | 0.140 |
Why?
|
| Adult | 12 | 2024 | 81933 | 0.130 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2018 | 255 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2017 | 298 | 0.130 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2021 | 1054 | 0.130 |
Why?
|
| Hydroxyurea | 1 | 2016 | 224 | 0.130 |
Why?
|
| Databases, Genetic | 1 | 2019 | 751 | 0.130 |
Why?
|
| Immunosuppressive Agents | 2 | 2018 | 1443 | 0.130 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2004 | 2472 | 0.120 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 1409 | 0.120 |
Why?
|
| Neurodegenerative Diseases | 1 | 2018 | 277 | 0.120 |
Why?
|
| Female | 16 | 2024 | 149288 | 0.120 |
Why?
|
| Infant, Newborn | 4 | 2020 | 8612 | 0.120 |
Why?
|
| Brain Neoplasms | 2 | 2018 | 4994 | 0.120 |
Why?
|
| Clonal Evolution | 1 | 2016 | 251 | 0.120 |
Why?
|
| Kidney Failure, Chronic | 2 | 2018 | 962 | 0.110 |
Why?
|
| Cluster Analysis | 1 | 2016 | 1074 | 0.110 |
Why?
|
| Genetic Testing | 2 | 2021 | 1699 | 0.110 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 1659 | 0.110 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2016 | 582 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 1615 | 0.110 |
Why?
|
| Genome-Wide Association Study | 2 | 2018 | 2333 | 0.100 |
Why?
|
| Germ-Line Mutation | 1 | 2017 | 1102 | 0.100 |
Why?
|
| STAT3 Transcription Factor | 1 | 2018 | 1146 | 0.100 |
Why?
|
| Cardiac Output | 1 | 2011 | 197 | 0.090 |
Why?
|
| Transplantation Conditioning | 1 | 2020 | 2359 | 0.090 |
Why?
|
| Exome | 1 | 2016 | 1252 | 0.090 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2016 | 1068 | 0.090 |
Why?
|
| Genome, Human | 1 | 2018 | 1885 | 0.080 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 1439 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 4400 | 0.080 |
Why?
|
| Mycophenolic Acid | 2 | 2018 | 154 | 0.080 |
Why?
|
| Monitoring, Physiologic | 1 | 2011 | 537 | 0.080 |
Why?
|
| Treatment Outcome | 7 | 2024 | 33909 | 0.070 |
Why?
|
| Oxygen | 1 | 2011 | 800 | 0.070 |
Why?
|
| Biopsy | 3 | 2018 | 3544 | 0.070 |
Why?
|
| Lymph Nodes | 1 | 2017 | 3080 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 7958 | 0.070 |
Why?
|
| Diagnosis, Differential | 3 | 2021 | 4900 | 0.070 |
Why?
|
| Recurrence | 2 | 2024 | 4887 | 0.060 |
Why?
|
| Anemia | 1 | 2011 | 730 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2020 | 6987 | 0.060 |
Why?
|
| Paresis | 1 | 2004 | 55 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 5187 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 5756 | 0.060 |
Why?
|
| Epilepsies, Partial | 1 | 2004 | 119 | 0.050 |
Why?
|
| Clone Cells | 1 | 2004 | 589 | 0.050 |
Why?
|
| Adenine Nucleotides | 1 | 2024 | 365 | 0.050 |
Why?
|
| Renal Dialysis | 2 | 2018 | 931 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2004 | 12012 | 0.050 |
Why?
|
| Arabinonucleosides | 1 | 2024 | 458 | 0.050 |
Why?
|
| Prognosis | 1 | 2019 | 22555 | 0.050 |
Why?
|
| Bone Marrow | 2 | 2018 | 2446 | 0.050 |
Why?
|
| Exons | 1 | 2004 | 1388 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2004 | 638 | 0.040 |
Why?
|
| Mannose-Binding Lectins | 1 | 2020 | 29 | 0.040 |
Why?
|
| Antigens, CD1 | 1 | 2020 | 48 | 0.040 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 194 | 0.040 |
Why?
|
| Autoimmunity | 1 | 2021 | 270 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2020 | 163 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2019 | 151 | 0.040 |
Why?
|
| Immunity | 1 | 2021 | 356 | 0.040 |
Why?
|
| Histoplasma | 1 | 2018 | 35 | 0.040 |
Why?
|
| Antigens, Fungal | 1 | 2018 | 44 | 0.040 |
Why?
|
| Spinal Neoplasms | 1 | 2004 | 666 | 0.040 |
Why?
|
| Histoplasmosis | 1 | 2018 | 80 | 0.040 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2019 | 108 | 0.040 |
Why?
|
| Myeloid Cells | 1 | 2020 | 277 | 0.040 |
Why?
|
| Liver Failure | 1 | 2019 | 142 | 0.040 |
Why?
|
| Proteome | 1 | 2021 | 573 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2021 | 1364 | 0.040 |
Why?
|
| Amphotericin B | 1 | 2018 | 304 | 0.040 |
Why?
|
| Biomarkers | 2 | 2020 | 5115 | 0.040 |
Why?
|
| Gain of Function Mutation | 1 | 2018 | 134 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2017 | 6236 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2018 | 738 | 0.040 |
Why?
|
| Multifactorial Inheritance | 1 | 2018 | 163 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 2021 | 954 | 0.040 |
Why?
|
| Age of Onset | 1 | 2019 | 855 | 0.040 |
Why?
|
| Drug Eruptions | 1 | 2019 | 271 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2021 | 1095 | 0.030 |
Why?
|
| Viral Load | 1 | 2018 | 482 | 0.030 |
Why?
|
| Drug Therapy | 1 | 2017 | 206 | 0.030 |
Why?
|
| Middle Aged | 3 | 2024 | 90460 | 0.030 |
Why?
|
| Mexico | 1 | 2016 | 275 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2020 | 792 | 0.030 |
Why?
|
| Neoplastic Stem Cells | 1 | 2004 | 1469 | 0.030 |
Why?
|
| Cytomegalovirus | 1 | 2018 | 493 | 0.030 |
Why?
|
| Salvage Therapy | 1 | 2024 | 2119 | 0.030 |
Why?
|
| Fetal Diseases | 1 | 2019 | 449 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2020 | 1436 | 0.030 |
Why?
|
| Cytomegalovirus Infections | 1 | 2018 | 487 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2019 | 721 | 0.030 |
Why?
|
| Pyrroles | 1 | 2018 | 592 | 0.030 |
Why?
|
| Medication Adherence | 1 | 2018 | 520 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2020 | 1113 | 0.030 |
Why?
|
| Disease Management | 1 | 2019 | 1113 | 0.030 |
Why?
|
| Nitriles | 1 | 2018 | 945 | 0.030 |
Why?
|
| Family | 1 | 2017 | 779 | 0.030 |
Why?
|
| Piperidines | 1 | 2018 | 1091 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2018 | 1255 | 0.020 |
Why?
|
| Lactates | 1 | 2011 | 123 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2018 | 1373 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2024 | 4496 | 0.020 |
Why?
|
| Vascular Resistance | 1 | 2011 | 215 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2017 | 1423 | 0.020 |
Why?
|
| Oximetry | 1 | 2011 | 189 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 7237 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2018 | 1544 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2011 | 485 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 3856 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2017 | 5788 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2024 | 39831 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 2011 | 583 | 0.020 |
Why?
|
| Phenotype | 1 | 2019 | 6517 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 7476 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 3176 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2018 | 3664 | 0.020 |
Why?
|
| Texas | 1 | 2016 | 6440 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 4640 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 9500 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2011 | 1603 | 0.020 |
Why?
|
| Aged | 2 | 2024 | 73517 | 0.020 |
Why?
|
| Brain | 1 | 2018 | 4257 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 10259 | 0.010 |
Why?
|
| Survival Rate | 1 | 2016 | 12534 | 0.010 |
Why?
|
| Mice | 1 | 2021 | 36053 | 0.010 |
Why?
|
| Risk Factors | 1 | 2016 | 18051 | 0.010 |
Why?
|
| United States | 1 | 2016 | 16066 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 13139 | 0.010 |
Why?
|
| Animals | 1 | 2021 | 62822 | 0.010 |
Why?
|
| Neoplasms | 1 | 2019 | 15930 | 0.010 |
Why?
|